Laboratory Research
One of the most prevalent complications of type 2 diabetes is limb amputation caused by diabetic foot ulcer (DFU). The exposure to high glucose changes the normal cell physiology, decreases cell proliferation and migration, promotes de abnormal expression of growth factors, and impairs immune function. These changes make the treatment of DFU to be a constant challenge in diabetes care.
This study evaluated a novel skin graft to improve the wound healing in a glycated microenvironment. This skin graft is a full epidermis genetically modified using a no replicative type 5 adenovirus to express two important growth factors: Human insulin and VEGF165. It reduces advanced glycation end products (AGEs) and enhances the formation vascular network to supply the area of healing.